Tetra Radar · Company Timeline
Bristol Myers Squibb Co (BMY)
Sector: Health Care
Earlier observations
- · FDA approval. The FDA approved Zenbexus to be used in combination with daratumumab and hyaluronidase-fihj and dexamethasone for adults with multiple myeloma who have received at least one prior line of therapy, including a proteasome inhibitor and an immunomodulatory agent.
Observations from the last 30 days, with Clusters and Heat Signatures, are in the Tetra Radar Library.
Dates are event dates. Tetra Radar observes public information for research purposes. It does not provide investment advice.